Symbols / EMBC Stock $9.15 -0.65% Embecta Corp.
EMBC (Stock) Chart
About
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Stock Fundamentals
Scroll to Statements| Market Cap | 541.86M | Enterprise Value | 1.75B | Income | 139.50M | Sales | 1.08B | Book/sh | -10.35 | Cash/sh | 3.40 |
| Dividend Yield | 6.51% | Payout | 25.42% | Employees | 1850 | IPO | — | P/E | 3.88 | Forward P/E | 3.18 |
| PEG | — | P/S | 0.50 | P/B | -0.88 | P/C | — | EV/EBITDA | 4.78 | EV/Sales | 1.62 |
| Quick Ratio | 1.54 | Current Ratio | 2.64 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | 2.36 | EPS next Y | 2.88 |
| EPS Growth | — | Revenue Growth | -0.30% | Earnings | 2026-05-05 | ROA | 18.36% | ROE | — | ROIC | — |
| Gross Margin | 63.16% | Oper. Margin | 29.21% | Profit Margin | 12.92% | Shs Outstand | 59.22M | Shs Float | 58.30M | Short Float | 10.62% |
| Short Ratio | 5.70 | Short Interest | — | 52W High | 15.55 | 52W Low | 8.47 | Beta | 1.10 | Avg Volume | 879.10K |
| Volume | 552.24K | Target Price | $15.00 | Recom | Hold | Prev Close | $9.21 | Price | $9.15 | Change | -0.65% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-13 | main | Mizuho | Neutral → Neutral | $12 |
| 2026-02-06 | reit | BTIG | Buy → Buy | $25 |
| 2025-09-05 | reit | BTIG | Buy → Buy | $25 |
| 2025-07-16 | main | Mizuho | Neutral → Neutral | $12 |
| 2025-05-23 | main | Mizuho | Neutral → Neutral | $13 |
| 2025-04-10 | init | Mizuho | — → Neutral | $15 |
| 2024-11-27 | up | BTIG | Neutral → Buy | $26 |
| 2024-07-15 | main | Morgan Stanley | Underweight → Underweight | $12 |
| 2024-05-10 | main | Morgan Stanley | Underweight → Underweight | $13 |
| 2023-11-22 | main | Morgan Stanley | Underweight → Underweight | $16 |
| 2023-10-18 | main | Morgan Stanley | Underweight → Underweight | $15 |
| 2023-08-24 | main | Morgan Stanley | Underweight → Underweight | $16 |
| 2023-07-18 | main | Morgan Stanley | Underweight → Underweight | $19 |
| 2023-05-15 | main | Morgan Stanley | Underweight → Underweight | $29 |
| 2023-01-06 | down | Morgan Stanley | Equal-Weight → Underweight | $28 |
| 2022-12-21 | main | Morgan Stanley | — → Equal-Weight | $31 |
| 2022-10-11 | main | Morgan Stanley | — → Equal-Weight | $33 |
| 2022-09-08 | init | BTIG | — → Neutral | — |
| 2022-08-16 | main | Morgan Stanley | — → Equal-Weight | $36 |
| 2022-08-01 | init | Morgan Stanley | — → Equal-Weight | $33 |
- embecta investors get Q2 results and business update on May 5 - Stock Titan ue, 21 Apr 2026 21
- EMBC (Embecta Corp.) delivers Q1 2026 earnings above expectations, shares climb as investors overlook mild yearly revenue declines. - Trading Community - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 04
- What is the outlook for Embecta (EMBC) stock this quarter (At Highs) 2026-04-20 - Alpha Picks - Cổng thông tin điện tử Tỉnh Sơn La Mon, 20 Apr 2026 16
- Is Embecta (EMBC) One of the 10 Healthcare Stocks with Highest Dividends? - Yahoo Finance Fri, 17 Apr 2026 18
- What is the outlook for Embecta (EMBC) stock this quarter (At Highs) 2026-04-20 - Fast Moving Stocks - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 16
- Why Embecta Stock Is Down 20% This Week - TIKR.com hu, 27 Nov 2025 08
- Embecta (EMBC) Stock Price Today & Analysis - Gotrade ue, 16 Dec 2025 20
- Embecta Corp. (EMBC) Stock Analysis: Exploring a 57.73% Potential Upside in the Medical Instruments Space - DirectorsTalk Interviews Fri, 17 Apr 2026 09
- Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat - ChartMill hu, 05 Feb 2026 08
- Embecta stock ticks up on Street-beating Q1 - Drug Delivery Business hu, 05 Feb 2026 08
- We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance hu, 12 Feb 2026 08
- EMBC (Embecta Corp.) delivers narrow Q1 2026 EPS beat, shares dip slightly on soft year over year revenue results. - Earnings Per Share - Xã Thanh Hà hu, 23 Apr 2026 03
- Is Embecta Corp. (NASDAQ:EMBC) Potentially Undervalued? - Yahoo Finance Fri, 31 Oct 2025 07
- Does Embecta (EMBC) Stock pay reliable income | Price at $8.95, Up 0.85% - Fast Moving Stocks - Cổng thông tin điện tử Tỉnh Sơn La Fri, 10 Apr 2026 07
- Embecta Insider Ups Holding By 13% During Year - simplywall.st Sat, 18 Apr 2026 14
Insider Transactions
Financials
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,080.40
-3.80%
|
1,123.10
+0.21%
|
1,120.80
-0.77%
|
1,129.50
|
| Operating Revenue |
|
1,080.40
-3.80%
|
1,123.10
+0.21%
|
1,120.80
-0.77%
|
1,129.50
|
| Cost Of Revenue |
|
403.60
+4.05%
|
387.90
+4.58%
|
370.90
+4.60%
|
354.60
|
| Reconciled Cost Of Revenue |
|
373.30
+4.27%
|
358.00
-3.48%
|
370.90
+4.60%
|
354.60
|
| Gross Profit |
|
676.80
-7.94%
|
735.20
-1.96%
|
749.90
-3.23%
|
774.90
|
| Operating Expense |
|
380.40
-15.50%
|
450.20
-14.39%
|
525.90
+29.40%
|
406.40
|
| Research And Development |
|
37.30
-52.66%
|
78.80
-7.51%
|
85.20
+27.35%
|
66.90
|
| Selling General And Administration |
|
332.00
-9.07%
|
365.10
+6.97%
|
341.30
+15.77%
|
294.80
|
| Selling And Marketing Expense |
|
—
|
—
|
—
|
—
|
| Other Operating Expenses |
|
0.70
|
—
|
99.40
+122.37%
|
44.70
|
| Total Expenses |
|
784.00
-6.46%
|
838.10
-6.55%
|
896.80
+17.84%
|
761.00
|
| Operating Income |
|
296.40
+4.00%
|
285.00
+27.23%
|
224.00
-39.21%
|
368.50
|
| Total Operating Income As Reported |
|
242.10
+45.14%
|
166.80
-24.70%
|
221.50
-28.46%
|
309.60
|
| EBITDA |
|
284.30
+47.54%
|
192.70
-21.44%
|
245.30
-26.67%
|
334.50
|
| Normalized EBITDA |
|
338.60
+8.91%
|
310.90
+25.46%
|
247.80
-37.01%
|
393.40
|
| Reconciled Depreciation |
|
40.70
+12.43%
|
36.20
+11.04%
|
32.60
+2.84%
|
31.70
|
| EBIT |
|
243.60
+55.65%
|
156.50
-26.42%
|
212.70
-29.76%
|
302.80
|
| Total Unusual Items |
|
-54.30
+54.06%
|
-118.20
-4628.00%
|
-2.50
+95.76%
|
-58.90
|
| Total Unusual Items Excluding Goodwill |
|
-54.30
+54.06%
|
-118.20
-4628.00%
|
-2.50
+95.76%
|
-58.90
|
| Special Income Charges |
|
-54.30
+54.06%
|
-118.20
-4628.00%
|
-2.50
+95.76%
|
-58.90
|
| Other Special Charges |
|
15.70
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
0.00
|
0.00
-100.00%
|
2.50
-95.76%
|
58.90
|
| Restructuring And Mergern Acquisition |
|
38.60
-67.34%
|
118.20
+20.24%
|
98.30
|
—
|
| Net Income |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Pretax Income |
|
136.30
+208.37%
|
44.20
-58.18%
|
105.70
-58.81%
|
256.60
|
| Net Non Operating Interest Income Expense |
|
-107.30
+4.45%
|
-112.30
-4.95%
|
-107.00
-131.60%
|
-46.20
|
| Interest Expense Non Operating |
|
107.30
-4.45%
|
112.30
+4.95%
|
107.00
+131.60%
|
46.20
|
| Net Interest Income |
|
-107.30
+4.45%
|
-112.30
-4.95%
|
-107.00
-131.60%
|
-46.20
|
| Interest Expense |
|
107.30
-4.45%
|
112.30
+4.95%
|
107.00
+131.60%
|
46.20
|
| Other Income Expense |
|
-52.80
+58.91%
|
-128.50
-1037.17%
|
-11.30
+82.80%
|
-65.70
|
| Other Non Operating Income Expenses |
|
1.50
+114.56%
|
-10.30
-17.05%
|
-8.80
-29.41%
|
-6.80
|
| Tax Provision |
|
40.90
+219.94%
|
-34.10
-196.60%
|
35.30
+6.97%
|
33.00
|
| Tax Rate For Calcs |
|
0.00
+42.86%
|
0.00
-37.13%
|
0.00
+158.91%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-16.29
+34.37%
|
-24.82
-2872.69%
|
-0.83
+89.01%
|
-7.60
|
| Net Income Including Noncontrolling Interests |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Net Income From Continuing Operation Net Minority Interest |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Net Income From Continuing And Discontinued Operation |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Net Income Continuous Operations |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Normalized Income |
|
133.41
-22.29%
|
171.68
+138.23%
|
72.06
-73.79%
|
274.90
|
| Net Income Common Stockholders |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Diluted EPS |
|
1.62
+20.90%
|
1.34
+9.84%
|
1.22
-68.64%
|
3.89
|
| Basic EPS |
|
1.64
+20.59%
|
1.36
+10.57%
|
1.23
-68.62%
|
3.92
|
| Basic Average Shares |
|
58.17
+1.04%
|
57.57
+0.59%
|
57.24
+0.34%
|
57.04
|
| Diluted Average Shares |
|
58.91
+1.01%
|
58.33
+1.08%
|
57.70
+0.39%
|
57.48
|
| Diluted NI Availto Com Stockholders |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Amortization |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Amortization Of Intangibles Income Statement |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Depreciation Amortization Depletion Income Statement |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Depreciation And Amortization In Income Statement |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Assets |
|
1,090.90
-15.12%
|
1,285.30
+5.84%
|
1,214.40
+11.78%
|
1,086.40
|
| Current Assets |
|
631.40
-17.03%
|
761.00
+1.59%
|
749.10
+12.70%
|
664.70
|
| Cash Cash Equivalents And Short Term Investments |
|
225.50
-15.70%
|
267.50
-18.02%
|
326.30
-1.39%
|
330.90
|
| Cash And Cash Equivalents |
|
225.50
-15.70%
|
267.50
-18.02%
|
326.30
-1.39%
|
330.90
|
| Receivables |
|
148.90
-39.67%
|
246.80
+55.12%
|
159.10
+19.53%
|
133.10
|
| Accounts Receivable |
|
145.60
-24.56%
|
193.00
+1055.69%
|
16.70
-24.77%
|
22.20
|
| Gross Accounts Receivable |
|
147.40
-24.72%
|
195.80
+1006.21%
|
17.70
-24.68%
|
23.50
|
| Allowance For Doubtful Accounts Receivable |
|
-1.80
+35.71%
|
-2.80
-180.00%
|
-1.00
+23.08%
|
-1.30
|
| Inventory |
|
178.60
+4.14%
|
171.50
+12.75%
|
152.10
+23.86%
|
122.80
|
| Raw Materials |
|
50.00
+23.76%
|
40.40
+25.86%
|
32.10
+37.18%
|
23.40
|
| Work In Process |
|
11.70
+143.75%
|
4.80
-40.74%
|
8.10
+44.64%
|
5.60
|
| Finished Goods |
|
116.90
-7.44%
|
126.30
+12.87%
|
111.90
+19.30%
|
93.80
|
| Prepaid Assets |
|
—
|
—
|
—
|
77.90
|
| Restricted Cash |
|
3.10
-53.73%
|
6.70
+3250.00%
|
0.20
|
—
|
| Other Current Assets |
|
75.30
+9.93%
|
68.50
-38.51%
|
111.40
+43.00%
|
77.90
|
| Total Non Current Assets |
|
459.50
-12.36%
|
524.30
+12.68%
|
465.30
+10.34%
|
421.70
|
| Net PPE |
|
257.20
-11.43%
|
290.40
-3.26%
|
300.20
-0.46%
|
301.60
|
| Gross PPE |
|
791.30
+1.57%
|
779.10
+4.17%
|
747.90
+6.60%
|
701.60
|
| Accumulated Depreciation |
|
-534.10
-9.29%
|
-488.70
-9.16%
|
-447.70
-11.92%
|
-400.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
3.10
+0.00%
|
3.10
+34.78%
|
2.30
+64.29%
|
1.40
|
| Buildings And Improvements |
|
121.00
-0.58%
|
121.70
-2.25%
|
124.50
+0.65%
|
123.70
|
| Machinery Furniture Equipment |
|
595.40
-1.96%
|
607.30
+7.07%
|
567.20
+12.29%
|
505.10
|
| Construction In Progress |
|
58.60
+66.95%
|
35.10
-21.65%
|
44.80
-30.97%
|
64.90
|
| Leases |
|
13.20
+10.92%
|
11.90
+30.77%
|
9.10
+40.00%
|
6.50
|
| Goodwill And Other Intangible Assets |
|
22.40
-5.49%
|
23.70
-4.05%
|
24.70
+0.41%
|
24.60
|
| Goodwill |
|
15.40
-1.28%
|
15.60
+0.00%
|
15.60
-0.64%
|
15.70
|
| Other Intangible Assets |
|
7.00
-13.58%
|
8.10
-10.99%
|
9.10
+2.25%
|
8.90
|
| Non Current Deferred Assets |
|
—
|
—
|
—
|
95.50
|
| Non Current Deferred Taxes Assets |
|
—
|
—
|
—
|
95.50
|
| Other Non Current Assets |
|
179.90
-14.41%
|
210.20
+49.72%
|
140.40
+47.02%
|
95.50
|
| Total Liabilities Net Minority Interest |
|
1,742.10
-13.94%
|
2,024.20
-0.58%
|
2,036.10
+2.95%
|
1,977.80
|
| Current Liabilities |
|
261.50
-30.08%
|
374.00
+5.80%
|
353.50
+17.44%
|
301.00
|
| Payables And Accrued Expenses |
|
248.60
-31.15%
|
361.10
+6.08%
|
340.40
+18.24%
|
287.90
|
| Payables |
|
100.30
-37.39%
|
160.20
+0.00%
|
160.20
+18.58%
|
135.10
|
| Accounts Payable |
|
74.20
-18.46%
|
91.00
+70.09%
|
53.50
+29.23%
|
41.40
|
| Current Accrued Expenses |
|
148.30
-26.18%
|
200.90
+11.49%
|
180.20
+17.93%
|
152.80
|
| Total Tax Payable |
|
9.80
-63.30%
|
26.70
-20.54%
|
33.60
+23.53%
|
27.20
|
| Income Tax Payable |
|
9.80
-63.30%
|
26.70
-20.54%
|
33.60
+23.53%
|
27.20
|
| Current Debt And Capital Lease Obligation |
|
12.90
+0.00%
|
12.90
-1.53%
|
13.10
+0.00%
|
13.10
|
| Current Debt |
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
|
| Other Current Borrowings |
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
|
| Current Capital Lease Obligation |
|
3.40
+0.00%
|
3.40
-5.56%
|
3.60
+0.00%
|
3.60
|
| Total Non Current Liabilities Net Minority Interest |
|
1,480.60
-10.28%
|
1,650.20
-1.93%
|
1,682.60
+0.35%
|
1,676.80
|
| Long Term Debt And Capital Lease Obligation |
|
1,417.40
-11.16%
|
1,595.50
-1.84%
|
1,625.40
-0.33%
|
1,630.70
|
| Long Term Debt |
|
1,388.70
-11.28%
|
1,565.30
-1.79%
|
1,593.90
-0.26%
|
1,598.10
|
| Long Term Capital Lease Obligation |
|
28.70
-4.97%
|
30.20
-4.13%
|
31.50
-3.37%
|
32.60
|
| Non Current Deferred Liabilities |
|
—
|
—
|
—
|
46.10
|
| Non Current Deferred Taxes Liabilities |
|
—
|
—
|
—
|
46.10
|
| Other Non Current Liabilities |
|
63.20
+15.54%
|
54.70
-4.37%
|
57.20
+24.08%
|
46.10
|
| Stockholders Equity |
|
-651.20
+11.87%
|
-738.90
+10.08%
|
-821.70
+7.82%
|
-891.40
|
| Common Stock Equity |
|
-651.20
+11.87%
|
-738.90
+10.08%
|
-821.70
+7.82%
|
-891.40
|
| Capital Stock |
|
0.00
|
0.00
-100.00%
|
0.60
+0.00%
|
0.60
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.60
+0.00%
|
0.60
|
| Share Issued |
|
58.50
+1.37%
|
57.71
+0.65%
|
57.33
+0.49%
|
57.06
|
| Ordinary Shares Number |
|
58.50
+1.37%
|
57.71
+0.65%
|
57.33
+0.49%
|
57.06
|
| Additional Paid In Capital |
|
80.00
+52.38%
|
52.50
+88.17%
|
27.90
+179.00%
|
10.00
|
| Retained Earnings |
|
-445.60
+10.63%
|
-498.60
+7.85%
|
-541.10
+6.24%
|
-577.10
|
| Gains Losses Not Affecting Retained Earnings |
|
-285.60
+2.46%
|
-292.80
+5.27%
|
-309.10
+4.86%
|
-324.90
|
| Other Equity Adjustments |
|
-285.60
+2.46%
|
-292.80
+5.27%
|
-309.10
+4.86%
|
-324.90
|
| Total Equity Gross Minority Interest |
|
-651.20
+11.87%
|
-738.90
+10.08%
|
-821.70
+7.82%
|
-891.40
|
| Total Capitalization |
|
737.50
-10.76%
|
826.40
+7.02%
|
772.20
+9.27%
|
706.70
|
| Working Capital |
|
369.90
-4.42%
|
387.00
-2.17%
|
395.60
+8.77%
|
363.70
|
| Invested Capital |
|
747.00
-10.64%
|
835.90
+6.93%
|
781.70
+9.15%
|
716.20
|
| Total Debt |
|
1,430.30
-11.07%
|
1,608.40
-1.84%
|
1,638.50
-0.32%
|
1,643.80
|
| Net Debt |
|
1,172.70
-10.30%
|
1,307.30
+2.36%
|
1,277.10
+0.03%
|
1,276.70
|
| Capital Lease Obligations |
|
32.10
-4.46%
|
33.60
-4.27%
|
35.10
-3.04%
|
36.20
|
| Net Tangible Assets |
|
-673.60
+11.67%
|
-762.60
+9.90%
|
-846.40
+7.60%
|
-916.00
|
| Tangible Book Value |
|
-673.60
+11.67%
|
-762.60
+9.90%
|
-846.40
+7.60%
|
-916.00
|
| Duefrom Related Parties Current |
|
3.30
-93.87%
|
53.80
-62.22%
|
142.40
+28.40%
|
110.90
|
| Dueto Related Parties Current |
|
16.30
-61.65%
|
42.50
-41.86%
|
73.10
+9.92%
|
66.50
|
| Other Equity Interest |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
191.70
+436.97%
|
35.70
-47.27%
|
67.70
-83.58%
|
412.20
|
| Cash Flow From Continuing Operating Activities |
|
191.70
+436.97%
|
35.70
-47.27%
|
67.70
-83.58%
|
412.20
|
| Net Income From Continuing Operations |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Depreciation Amortization Depletion |
|
40.70
+12.43%
|
36.20
+11.04%
|
32.60
+2.84%
|
31.70
|
| Depreciation And Amortization |
|
40.70
+12.43%
|
36.20
+11.04%
|
32.60
+2.84%
|
31.70
|
| Other Non Cash Items |
|
19.50
+47.73%
|
13.20
+106.25%
|
6.40
+100.00%
|
3.20
|
| Pension And Employee Benefit Expense |
|
—
|
—
|
—
|
10.20
|
| Stock Based Compensation |
|
31.60
+20.15%
|
26.30
+22.33%
|
21.50
+14.97%
|
18.70
|
| Asset Impairment Charge |
|
10.60
|
0.00
-100.00%
|
2.50
-95.76%
|
58.90
|
| Deferred Tax |
|
17.60
+124.93%
|
-70.60
-593.71%
|
14.30
+153.96%
|
-26.50
|
| Deferred Income Tax |
|
17.60
+124.93%
|
-70.60
-593.71%
|
14.30
+153.96%
|
-26.50
|
| Operating Gains Losses |
|
—
|
—
|
—
|
10.20
|
| Change In Working Capital |
|
-23.70
+50.31%
|
-47.70
+40.38%
|
-80.00
-177.97%
|
102.60
|
| Change In Receivables |
|
44.20
+125.30%
|
-174.70
-2595.71%
|
7.00
-94.30%
|
122.70
|
| Changes In Account Receivables |
|
44.20
+125.30%
|
-174.70
-2595.71%
|
7.00
-94.30%
|
122.70
|
| Change In Inventory |
|
-6.10
+63.03%
|
-16.50
+42.71%
|
-28.80
-23.08%
|
-23.40
|
| Change In Prepaid Assets |
|
8.50
-78.48%
|
39.50
+378.17%
|
-14.20
+67.73%
|
-44.00
|
| Change In Payables And Accrued Expense |
|
-97.00
-232.51%
|
73.20
+1657.45%
|
-4.70
-105.39%
|
87.20
|
| Change In Payable |
|
-97.00
-232.51%
|
73.20
+1657.45%
|
-4.70
-105.39%
|
87.20
|
| Change In Account Payable |
|
-68.90
-214.83%
|
60.00
+659.49%
|
7.90
-89.73%
|
76.90
|
| Change In Other Working Capital |
|
26.70
-13.31%
|
30.80
+178.37%
|
-39.30
+1.50%
|
-39.90
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
0.50
|
| Investing Cash Flow |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-10.42%
|
-24.00
|
| Cash Flow From Continuing Investing Activities |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-10.42%
|
-24.00
|
| Capital Expenditure |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-10.42%
|
-24.00
|
| Capital Expenditure Reported |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-12.29%
|
-23.60
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
|
0.00
+100.00%
|
-0.40
|
| Purchase Of Intangibles |
|
—
|
0.00
|
0.00
+100.00%
|
-0.40
|
| Financing Cash Flow |
|
-226.70
-208.86%
|
-73.40
-50.72%
|
-48.70
-1.46%
|
-48.00
|
| Cash Flow From Continuing Financing Activities |
|
-226.70
-208.86%
|
-73.40
-50.72%
|
-48.70
-1.46%
|
-48.00
|
| Net Issuance Payments Of Debt |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
-100.74%
|
1,437.80
|
| Issuance Of Debt |
|
—
|
0.00
|
0.00
-100.00%
|
1,450.00
|
| Repayment Of Debt |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
+12.30%
|
-12.20
|
| Long Term Debt Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
1,450.00
|
| Long Term Debt Payments |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
-62.12%
|
-6.60
|
| Net Long Term Debt Issuance |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
-100.74%
|
1,443.40
|
| Short Term Debt Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-5.60
|
| Net Short Term Debt Issuance |
|
—
|
0.00
|
0.00
+100.00%
|
-5.60
|
| Common Stock Dividend Paid |
|
-35.00
-1.45%
|
-34.50
-0.29%
|
-34.40
-300.00%
|
-8.60
|
| Cash Dividends Paid |
|
-35.00
-1.45%
|
-34.50
-0.29%
|
-34.40
-300.00%
|
-8.60
|
| Net Other Financing Charges |
|
-5.70
-90.00%
|
-3.00
+16.67%
|
-3.60
+99.76%
|
-1,477.20
|
| Changes In Cash |
|
-44.30
+17.20%
|
-53.50
-613.33%
|
-7.50
-102.20%
|
340.20
|
| Effect Of Exchange Rate Changes |
|
-1.30
-208.33%
|
1.20
-61.29%
|
3.10
+133.33%
|
-9.30
|
| Beginning Cash Position |
|
274.20
-16.02%
|
326.50
-1.33%
|
330.90
|
0.00
|
| End Cash Position |
|
228.60
-16.63%
|
274.20
-16.02%
|
326.50
-1.33%
|
330.90
|
| Free Cash Flow |
|
182.40
+816.58%
|
19.90
-51.70%
|
41.20
-89.39%
|
388.20
|
| Interest Paid Supplemental Data |
|
103.80
-11.81%
|
117.70
+6.04%
|
111.00
+185.35%
|
38.90
|
| Income Tax Paid Supplemental Data |
|
50.10
+72.16%
|
29.10
-4.28%
|
30.40
+94.87%
|
15.60
|
| Change In Income Tax Payable |
|
-28.10
-312.88%
|
13.20
+204.76%
|
-12.60
-222.33%
|
10.30
|
| Change In Tax Payable |
|
-28.10
-312.88%
|
13.20
+204.76%
|
-12.60
-222.33%
|
10.30
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-20 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 8-K2026-02-13 View
- 10-Q2026-02-05 View
- 8-K2026-02-05 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 10-K2025-11-25 View
- 8-K2025-11-25 View
- 8-K2025-11-17 View
- 42025-08-11 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|